Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg. 2014 Mar; 18(3):457-62; discussion 462-3.